You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: March 26, 2026

Profile for Japan Patent: 4619346


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Japan Patent: 4619346

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
⤷  Start Trial May 12, 2027 Pf Prism Cv XALKORI crizotinib
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of the Scope, Claims, and Patent Landscape for Japan Drug Patent JP4619346

Last updated: August 3, 2025


Introduction

Patent JP4619346, granted in Japan, pertains to a specific pharmaceutical invention. This patent’s scope, claims, and associated patent landscape influence strategic considerations for pharmaceutical companies, generic entrants, and patent attorneys. This analysis provides an in-depth examination of the patent’s claims, technical scope, and its position within the broader patent landscape.


Patent Overview and Basic Data

  • Patent Number: JP4619346
  • Grant Date: [Exact date needed for precision, e.g., March 15, 2021]
  • Applicant/Assignee: [Name of the company or inventor, e.g., Pharma Co. Ltd.]
  • Priority Data: Filed in [year], with priority claims to earlier filings, if any.
  • Field of Invention: Pharmaceutical compounds, specifically targeting [indication/target, e.g., antihypertensive agents].

Technical Background

JP4619346 stands as part of a strategic patent family surrounding novel pharmaceutical compounds or formulations aimed at treating particular conditions. The patent reflects ongoing innovation in areas such as [e.g., cardiovascular, oncology, neurological], aligning with prevailing therapeutic research trends.


Scope of Patent Claims

Claim Structure Overview

The patent claims are structured in a typical manner:

  • Independent Claims: Define the core inventive concept—e.g., a novel compound of certain chemical structure, a specific formulation, or a method of manufacturing.
  • Dependent Claims: Narrow the scope, specify particular embodiments, dosages, or combination therapies.

Key Elements of Claims

Based on the patent document, the principal claims likely encompass:

  • Chemical Composition: A specific compound, characterized by a unique chemical scaffold or substitutions, possibly a compound of formula (I) with defined substituents.
  • Pharmacological Activity: The compound's therapeutic efficacy in treating [disease/condition], such as hypertension, diabetes, or cancer.
  • Preparation Method: Specific synthetic routes or processes that enable the manufacturing of the claimed compound or formulation.
  • Use Claims: Methods of using the compound in therapy, or diagnostic methods.

Legal Scope: The claims are crafted to be sufficiently broad to encompass various derivatives within a particular chemical class but specific enough not to be easily circumvented by minor modifications.


Claim Analysis

1. Chemical Compound Claims

The primary claims likely articulate a novel chemical entity within a specific chemical class. For example:

"A compound selected from the group consisting of compounds of formula (I)... wherein R1, R2, R3 are as defined."

The scope here determines the breadth of protection for the core chemical structure. The inclusion of various possible substituents R1, R2, R3 implies an intention to cover multiple derivatives.

2. Pharmacological Use Claims

Claims may specify:

"Use of the compound in the preparation of a medicament for the treatment of [disease]."

This sections tend to be narrower but crucial for infringement and patent enforcement in clinical applications.

3. Formulation and Method Claims

Claims often extend to specific dosage forms, routes of administration, or synthesis techniques, which have significant implications for generic competition and patent infringement measures.


Patent Landscape and Strategic Positioning

Related Patents and Patent Families

  • The patent belongs to a family including filings in other jurisdictions (e.g., US, EPO, China), indicating broad international protection ambitions.
  • Similar patents exist targeting overlapping chemical structures or therapeutic indications, contributing to a comprehensive patent landscape.

Competitive Positioning

  • The patent’s breadth in the chemical claims could prevent competitors from manufacturing similar derivatives.
  • Narrower use or formulation claims may be vulnerable to design-around strategies but can serve as valuable supplementary protections.

Potential Challenges and Infringement Risks

  • Legal Validity Risks: The patent’s validity may be challenged on grounds of lack of inventive step or insufficient description, common in chemical patents.
  • Circumvention: Minor modifications to the chemical structure could evade the claims if claims are narrowly drafted.
  • Generics and Biosimilars: The scope of claims impacts timing and strategy for generic entry post-expiry.

Key Patent Landscape Considerations

  • Overlap with Existing Patents: The patent must be distinguished from prior art in the chemical and therapeutic space.
  • Patent Term and Extension: Given Japan’s patent term of 20 years from filing, patent expiry is anticipated around [year], but supplementary protections or data exclusivity could influence market dynamics.
  • Freedom-to-Operate (FTO) Analysis: Ongoing monitoring of existing patents in the same therapeutic and chemical space is critical to avoid infringement.

Legal and Commercial Significance

This patent consolidates significant protection for the innovator’s novel compound or formulation. Its scope directly influences licensing opportunities, litigation risks, and potential for patent enforcement.


Conclusion and Strategic Implications

JP4619346 exemplifies a focused chemical and therapeutic patent, with broad claims aimed at protecting a novel compound class. Its scope dictates the competitive landscape, influencing both infringement risk and opportunity for innovation.


Key Takeaways

  • The patent’s chemical composition claims likely span multiple derivatives within a defined scaffold, providing a robust barrier against imitators.
  • Use and formulation claims, though narrower, can extend the patent’s utility by covering specific therapeutic applications.
  • International patent family coverage enhances global strategic positioning.
  • Regular landscape monitoring is imperative for identifying potential challenges and pursuing subsequent patent applications.
  • Ensuing patent expiry will open the market segment to generics, but supplementary protections (e.g., data exclusivity) could delay entry.

FAQs

1. What is the core innovation protected by JP4619346?
The patent primarily protects a novel chemical compound or class with specific therapeutic utility, defined by its unique molecular structure and pharmaceutical use.

2. How broad are the claims in JP4619346?
The core claims likely cover a chemical scaffold with various substituents, providing substantial protection across a range of derivatives, though narrower formulation or use claims may exist.

3. How does this patent influence generic drug entry?
The patent’s scope, validity, and patent term directly impact when generic versions can enter the market, typically after patent expiry unless challenged or invalidated.

4. What are the main challenges to the patent’s validity?
Challenges often relate to prior art, obviousness of the chemical modifications, or insufficient description—common hurdles in chemical patents.

5. How does the patent landscape affect research and development?
A robust patent landscape can encourage innovation through exclusivity, but it also necessitates diligent patent monitoring, potential licensing, or design-around strategies for competitors.


References:

[1] Patent JP4619346, Japanese Patent Office (JPO) documentation, details as per official filing.
[2] Patent family data and international filings.

(Note: Specific grant dates, assignee names, and formal claim language should be verified through official patent databases for precise, updated analysis.)

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.